UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - PROMETHEUS BIOSCIENCES INC ownership

Back to all holdings Add to watchlist

PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 149 filers reported holding PROMETHEUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.60 and the average weighting 1.1%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of PROMETHEUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2023$1,979,8380.0%18,4480.0%0.00%0.0%
Q1 2023$1,979,838
-2.8%
18,448
-0.4%
0.00%0.0%
Q4 2022$2,037,640
-99.4%
18,524
+198.8%
0.00%–
Q3 2022$365,862,000
+56.3%
6,2000.0%0.00%–
Q1 2022$234,112,000–6,200–0.00%–
 Download
Other shareholders

There were no reported owners of PROMETHEUS BIOSCIENCES INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of PROMETHEUS BIOSCIENCES INC shareholders